Erin P. Ward

Erin P. Ward, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

801-587-4415

  • Erin P. Ward, MD is a surgical oncologist who specializes in the treatment of patients with abdominal cancers. She specializes in the surgical management of appendix cancer, neuroendocrine tumors, gastric cancer, and metastatic colorectal cancer. She is an expert in the treatment of peritoneal surface malignancies and other cancers that may have spread to the peritoneal lining, including the use of advanced therapies such as cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

    Dr. Ward is an Assistant Professor at the University of Utah; prior to joining she trained with world-renowned experts at the Medical College of Wisconsin and the University of California San Diego. Dr. Ward grew up in Michigan where she earned her medical degree at the College of Human Medicine at Michigan State University. She completed her general surgery residency and a two-year research fellowship at the University of California San Diego. She completed her training with a two-year Complex Surgical Oncology and completed an AHPBA Certified hepato-pancreatic biliary surgery fellowship at the Medical College of Wisconsin. She is board certified in both general surgery and complex general surgical oncology.

    Dr. Ward is one of two Commission on Cancer Liaison Physicians at the Huntsman Cancer Institute and actively pursuing research to understand better the impact of psychosocial health on cancer patient outcomes and patient-reported outcomes.

    Dr. Ward’s primary research focus is defining the impact of psychosocial health on the long-term and short-term outcomes for cancer patients.

    Dr. Ward’s clinical interests include:

    • Metastatic colorectal cancer
    • Appendiceal cancer
    • Gastric cancer
    • Neuroendocrine tumors
    • Minimally invasive surgery
    • Mesothelioma
    • Peritoneal based malignancies
    • HIPEC

    Specialties

    Board Certification

    American Board of Surgery
    American Board of Surgery (Sub: Complex General Surgical Oncology)

  • Erin P. Ward, MD is a surgical oncologist who specializes in the treatment of patients with abdominal cancers. She specializes in the surgical management of appendix cancer, neuroendocrine tumors, gastric cancer, and metastatic colorectal cancer. She is an expert in the treatment of peritoneal surface malignancies and other cancers that may have spread to the peritoneal lining, including the use of advanced therapies such as cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

    Dr. Ward is an Assistant Professor at the University of Utah; prior to joining she trained with world-renowned experts at the Medical College of Wisconsin and the University of California San Diego. Dr. Ward grew up in Michigan where she earned her medical degree at the College of Human Medicine at Michigan State University. She completed her general surgery residency and a two-year research fellowship at the University of California San Diego. She completed her training with a two-year Complex Surgical Oncology and completed an AHPBA Certified hepato-pancreatic biliary surgery fellowship at the Medical College of Wisconsin. She is board certified in both general surgery and complex general surgical oncology.

    Dr. Ward is one of two Commission on Cancer Liaison Physicians at the Huntsman Cancer Institute and actively pursuing research to understand better the impact of psychosocial health on cancer patient outcomes and patient-reported outcomes.

    Dr. Ward’s primary research focus is defining the impact of psychosocial health on the long-term and short-term outcomes for cancer patients.

    Dr. Ward’s clinical interests include:

    • Metastatic colorectal cancer
    • Appendiceal cancer
    • Gastric cancer
    • Neuroendocrine tumors
    • Minimally invasive surgery
    • Mesothelioma
    • Peritoneal based malignancies
    • HIPEC

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions General Surgery
    Board Certification
    American Board of Surgery
    American Board of Surgery (Sub: Complex General Surgical Oncology)

    Education history

    Fellowship Complex General Surgical Oncology - Medical College of Wisconsin Fellow
    Hepato-Pancreato-Biliary - Medical College of Wisconsin Fellow
    Chief Resident General Surgery - University of California, San Diego School of Medicine Administrative Chief Resident
    Surgical Oncology - University of California, San Diego School of Medicine Research Fellow
    Residency General Surgery - University of California, San Diego School of Medicine Resident
    Medicine - Michigan State University College of Human Medicine M.D.
    Undergraduate Physiology - Michigan State University B.S.
    Undergraduate Psychology; Specialization in Bioethics, Humanities and Society - Michigan State University B.S.

    Selected Publications

    Journal Article

    1. Ward EP, Okamuro L, Khan S, Hosseini M, Valasek MA, Ronquillo N Jr, Kelly KJ, Veerapong J, Lowy AM, Baumgartner J (2021). Ki67 does not predict recurrence for low-grade appendiceal mucinous neoplasms with peritoneal dissemination after cytoreductive surgery and HIPEC. Hum Pathol, 113, 104-110.
    2. Badaracco AG, Ward E, Barback C, Yang J, Wang J, Huang CH, Kim M, Wang Q, Nam S, Delong J, Blair S, Trogler WC, Kummel A (2019). Indocyanine green modified silica shells for colon tumor marking. Appl Surf Sci, 499.
    3. Weiss A, Lopez NE, Ward EP, Lee KC, Caudle AS, Dickson-Witmer D, Chang C, Kelly K, Martin LW, Jacobs LK, Hunt KK, Yao K, Blair SL (2019). Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC). Ann Surg Oncol, 26(13), 4364-4371.
    4. Wang A, Prieto JM, Ward E, Bickler S, Henry M, Kling K, Thangarajah H, Ignacio R Jr (2018). Operative treatment for intussusception: Should an incidental appendectomy be performed? J Pediatr Surg, 54(3), 495-499.
    5. Voss RK, Ward EP, Ojeda-Fournier H, Blair SL (2018). Doppler Ultrasound-Visible SignalMark Microspheres are Better Identified than HydroMARK® Clips in a Simulated Intraoperative Setting in Breast and Lung Tissue. Ann Surg Oncol, 25(12), 3740-3746.
    6. Ward EP, Yang J, Delong JC, Sung TW, Wang J, Barback C, Mendez N, Horgan S, Trogler W, Kummel AC, Blair SL (2018). Identifying lost surgical needles with visible and near infrared fluorescent light emitting microscale coating. Surgery, 163(4), 883-888.
    7. Langness S, Ward E, Halbach J, Lizardo R, Davenport K, Bickler S, Kling K, Thangarajah H, Grabowski J, Fairbanks T (2017). Plasma D-dimer safely reduces unnecessary CT scans obtained in the evaluation of pediatric head trauma. J Pediatr Surg, 53(4), 752-757.
    8. DeLong JC, Ward EP, Lwin TM, Brumund KT, Kelly KJ, Horgan S, Bouvet M (2017). Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism. Surgery, 163(2), 388-392.
    9. Ward EP, Wang A, Thangarajah H, Lazar D, Bickler S, Fairbanks T, Kling KM (2017). Preemptive Ladd Procedure in congenital diaphragmatic hernia and Abdominal Wall defects does not reduce the risk of future volvulus. J Pediatr Surg, 52(12), 1956-1961.
    10. Ward EP, Unkart JT, Bryant A, Murphy J, Blair SL (2017). Influence of Distance to Hospital and Insurance Status on the Rates of Contralateral Prophylactic Mastectomy, a National Cancer Data Base study. Ann Surg Oncol, 24(10), 3038-3047.
    11. Ward EP, Weiss A, Blair SL (2017). Incidence and treatments of DCIS in octogenarians: grade matters. Breast Cancer Res Treat, 165(2), 403-409.
    12. Yang J, Ward E, Sung TW, Wang J, Barback C, Mendez N, Blair S, Trogler WC, Kummel AC (2017). Silica Shells/Adhesive Composite Film for Color Doppler Ultrasound Guided Needle Placement. ACS Biomater Sci Eng, 3(8), 1780-1787.
    13. Yang J, Wang J, Ta CN, Ward E, Barback CV, Sung TW, Mendez N, Blair SL, Kummel AC, Trogler WC (2017). Ultrasound Responsive Macrophase-Segregated Microcomposite Films for in Vivo Biosensing. ACS Appl Mater Interfaces, 9(2), 1719-1727.
    14. Ward EP, Shiavazzi D, Sood D, Marsden A, Lane J, Owens E, Barleben A (2016). Computed Tomography Fractional Flow Reserve Can Identify Culprit Lesions in Aortoiliac Occlusive Disease Using Minimally Invasive Techniques. Ann Vasc Surg, 38, 151-157.
    15. Ward EP, Wang J, Mendez N, Yang J, Barback C, Wang-Rodriguez J, Trogler W, Kummel AC, Blair S (2016). Utilization of iron (III)-doped nanoshells for in vivo marking of nonpalpable tumors using a VX2 rabbit model. Am J Surg, 212(6), 1140-1146.
    16. Robles J, Weiss A, Ward EP, Unkart J, Blair SL (2016). Treatment of Breast Cancer in Women Aged 80 and Older: A Systematic Review. Breast Cancer: Current Research, 1(4).
    17. Weiss A, Lee KC, Romero Y, Ward E, Kim Y, Ojeda-Fournier H, Einck J, Blair SL (2014). Calcifications on mammogram do not correlate with tumor size after neoadjuvant chemotherapy. Ann Surg Oncol, 21(10), 3310-6.

    Review

    1. Ward EP, Zeh Iii HJ, Tsai S (2021). Current Controversies in Neoadjuvant Therapy for Pancreatic Cancer. [Review]. Surg Oncol Clin N Am, 30(4), 657-671.
    2. Ward EP, Evans DB, Tsai S (2020). Ten-year experience in optimizing neoadjuvant therapy for localized pancreatic cancer-Medical college of Wisconsin perspective. [Review]. J Surg Oncol, 123(6), 1405-1413.

    Case Report

    1. Weiss A, Ward EP, Baumgartner JM, Lowy AM, Kelly KJ (2018). Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients. World J Surg Oncol, 16(1), 87.
    2. Halbach J, Ward E, Langness S, Davenport K, Bickler SW, Fairbanks T, Kling K (2017). Gallbladder Polyps in Children: A Painful Inflammatory Process. Am Surg, 83(4), e140-142.

    Editorial

    1. Cortina CS, Ward EP, Kong AL (2021). The consideration for outpatient mastectomy during the COVID-19 global pandemic. Am J Surg, 222(2), 290-291.

  • Podcasts & News

    Huntsman Cancer Institute News

    The Scope Podcast